What is the address of SBMed?

The registered office of SBMed is located at Aux Houx(Cle) 39B, 4480 Engis.

Is SBMed still active?

Yes. According to the CBE (29 October 2026) SBMed is active, legal situation “Normale toestand”, started on 29 March 2021.

Is SBMed registered on Peppol?

Yes, SBMed is registered on the Peppol network with ID 0208:0765807872.

What is the enterprise number of SBMed?

The enterprise number of SBMed is BE0765807872.

When was SBMed founded?

SBMed was founded on 29 March 2021.

Is SBMed a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 March 2021; 4 annual accounts filed, latest fiscal year 2025.

How much profit did SBMed make in 2025?

SBMed posted a profit after taxes of € 74,964 in financial year 2025.

What is the revenue of SBMed?

In its most recent annual accounts (2025), SBMed reported revenue of € 247,911.

SBMed (Private Limited) - Engis - BE0765807872

Dossier SBMed, printed on 29 October 2026 from databakkes.be/en/0765807872/sbmed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 1 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 26 % of short-term debt in 2025; threshold 65 %.
Figures corrected NBB

Corrected annual account filed for 2025.

Financials

Financial year 2025

SBMed from Engis, company number BE0765807872, closed financial year 2025 with a result of € 74,964 after tax. For that financial year SBMed recorded revenue of € 247,911 and equity of € -65,143. Compared with financial year 2024, the result moved from € 74,585 to € 74,964. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Caution

€ -65,143

▼ € 67,143 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 74,964

▲ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 31,017

▼ 76% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 142,107 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 23,885

▼ 51% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 66,417

▼ 27% vs 2024

€ 15,857 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 24,130

▲ € 24,051 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 23,620

▼ 50% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	-	€ 247,911 Revenue 2025: € 247,911 First fiscal year in the series
Gross margin	€ 64,205 Gross margin 2022: € 64,205 First fiscal year in the series	€ 140,126 Gross margin 2023: € 140,126 ▲ 118% vs 2022 (€ 64,205) Favourable step	€ 174,407 Gross margin 2024: € 174,407 ▲ 24% vs 2023 (€ 140,126) Favourable step	€ 159,976 Gross margin 2025: € 159,976 ▼ 8% vs 2024 (€ 174,407) Unfavourable step	▼ 8%
Profit after taxes	€ 42,193 Profit after taxes 2022: € 42,193 First fiscal year in the series	€ 107,737 Profit after taxes 2023: € 107,737 ▲ 155% vs 2022 (€ 42,193) Favourable step	€ 74,585 Profit after taxes 2024: € 74,585 ▼ 31% vs 2023 (€ 107,737) Unfavourable step	€ 74,964 Profit after taxes 2025: € 74,964 ▲ 1% vs 2024 (€ 74,585) Favourable step	▲ 1%
Equity	€ 72,660 Equity 2022: € 72,660 First fiscal year in the series	€ 150,398 Equity 2023: € 150,398 ▲ 107% vs 2022 (€ 72,660) Favourable step	€ 2,000 Equity 2024: € 2,000 ▼ 99% vs 2023 (€ 150,398) Unfavourable step	€ -65,143 Equity 2025: € -65,143 ▼ € 67,143 vs 2024 (€ 2,000) Unfavourable step	▼ € 67,143
Total debts	€ 42,813 Total debts 2022: € 42,813 First fiscal year in the series	€ 144,482 Total debts 2023: € 144,482 ▲ 237% vs 2022 (€ 42,813) Unfavourable step	€ 294,044 Total debts 2024: € 294,044 ▲ 104% vs 2023 (€ 144,482) Unfavourable step	€ 256,275 Total debts 2025: € 256,275 ▼ 13% vs 2024 (€ 294,044) Favourable step	▼ 13%
Cash	€ 33,142 Cash 2022: € 33,142 First fiscal year in the series	€ 103,003 Cash 2023: € 103,003 ▲ 211% vs 2022 (€ 33,142) Favourable step	€ 130,473 Cash 2024: € 130,473 ▲ 27% vs 2023 (€ 103,003) Favourable step	€ 31,017 Cash 2025: € 31,017 ▼ 76% vs 2024 (€ 130,473) Unfavourable step	▼ 76%
Land & buildings	-	€ 59,080 Land & buildings 2023: € 59,080 First fiscal year in the series	€ 56,023 Land & buildings 2024: € 56,023 ▼ 5% vs 2023 (€ 59,080) Unchanged	€ 49,625 Land & buildings 2025: € 49,625 ▼ 11% vs 2024 (€ 56,023) Unchanged	▼ 11%
Retained profit	€ 70,660 Retained profit 2022: € 70,660 First fiscal year in the series	€ 148,398 Retained profit 2023: € 148,398 ▲ 110% vs 2022 (€ 70,660) Favourable step	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 148,398) Unfavourable step	€ -67,143 Retained profit 2025: € -67,143 Unchanged (€ 0) Unfavourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 30,000 Dividend 2023: € 30,000 Unchanged (€ 0) Unchanged	€ 222,983 Dividend 2024: € 222,983 ▲ € 192,983 vs 2023 (€ 30,000) Unchanged	€ 142,107 Dividend 2025: € 142,107 ▼ 36% vs 2024 (€ 222,983) Unchanged	▼ 36%
Bank debt	€ 35,674 Bank debt 2022: € 35,674 First fiscal year in the series	€ 118,868 Bank debt 2023: € 118,868 ▲ 233% vs 2022 (€ 35,674) Unfavourable step	€ 90,772 Bank debt 2024: € 90,772 ▼ 24% vs 2023 (€ 118,868) Favourable step	€ 66,417 Bank debt 2025: € 66,417 ▼ 27% vs 2024 (€ 90,772) Favourable step	▼ 27%
Balance sheet total	€ 115,473 Balance sheet total 2022: € 115,473 First fiscal year in the series	€ 294,879 Balance sheet total 2023: € 294,879 ▲ 155% vs 2022 (€ 115,473) Unchanged	€ 296,044 Balance sheet total 2024: € 296,044 Unchanged (€ 294,879) Unchanged	€ 191,132 Balance sheet total 2025: € 191,132 ▼ 35% vs 2024 (€ 296,044) Unchanged	▼ 35%

Key figures of SBMed, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to SBMed?

What happened at SBMed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
Apr 1, 2021 New establishment in Engis. KBO
Mar 29, 2021 Start of the company according to the CBE. KBO

In short

From € 42,193 profit in 2022 to € 74,964 profit in 2025.

Paid € 109,269 in corporate taxes since 2022.

Best year ever: 2023, with € 107,737 profit.

Paid out € 395,091 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Aux Houx(Cle) 39B

4480 Engis

2.315.988.727

Aux Houx(Cle) 39 box B

4480 Engis

Active since 1 April 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0765.807.872
VAT number: BE 0765.807.872
Registered office: Aux Houx(Cle) 39B, 4480 Engis
Names & denominations: SBMed
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 March 2021
Peppol: Active · Active since 12 Feb 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

SBMed